Accelerated repopulation during radiotherapy: Quantitative evidence for delayed onset

The time of onset of accelerated tumor-clonogen repopulation produced by radiotherapy is an important, but unresolved question. The suggestion by Withers et al. [Acta Oncol 27:131–146, 1988] and colleagues [Maciejewski and Majewski: Radiother Oncol 21:163–170, 1991] that onset is delayed has been questioned due to the variety of data sources and the methodology used to reach this conclusion. We describe an analysis of a single clinical data set, which allows a more credible estimate of the time of onset of accelerated repopulation. We analyze a recent report of tumor control of T2 and T3 laryngeal cancer as a function of dose and overall time. By virtue of their broad dynamic range, these results allow an estimate to be made of the time of onset of accelerated repopulation based on a single self-consistent data set. The analyses suggest that rapid proliferation in these tumors is delayed by an estimated 32 days (95% confidence limits of 21–36 days). For these laryngeal tumors, and within the framework of the linear-quadratic model, the hypothesis that accelerated repopulation begins at the start of radiotherapy can be rejected in favor of the suggestion that accelerated repopulation begins after 3–5 weeks. This conclusion, if generally true, would have significant ramifications for the design of optimized radiotherapeutic protocols. © 1993 Wiley-Liss, Inc.

[1]  O. W. Caldwell,et al.  THE CENTRAL ASSOCIATION OF SCIENCE AND MATHEMATICS TEACHERS , 1905 .

[2]  T. R. Munro,et al.  The relation between tumour lethal doses and the radiosensitivity of tumour cells. , 1961, The British journal of radiology.

[3]  N. Draper,et al.  Applied Regression Analysis , 1966 .

[4]  J. Andrews The radiobiology of human cancer radiotherapy , 1968 .

[5]  Tumour curability, cellular radiosensitivity and clonogenic cell number. , 1977, The British journal of radiology.

[6]  L. Šmid,et al.  Tumor cell repopulation in the rest interval of split-course radiation treatment. , 1980, Strahlentherapie.

[7]  K. Trott,et al.  The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. , 1981, International journal of radiation oncology, biology, physics.

[8]  C. D. Gelatt,et al.  Optimization by Simulated Annealing , 1983, Science.

[9]  S. Tucker,et al.  Isoeffect models and fractionated radiation therapy. , 1987, International journal of radiation oncology, biology, physics.

[10]  J. M. Taylor,et al.  The hazard of accelerated tumor clonogen repopulation during radiotherapy. , 1988, Acta oncologica.

[11]  J. Overgaard,et al.  Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. , 1988, Acta oncologica.

[12]  H D Thames,et al.  Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  H. Withers,et al.  Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  H. Thames,et al.  Clinical radiobiology of squamous cell carcinoma of the oropharynx. , 1991, International journal of radiation oncology, biology, physics.

[15]  S. Dische,et al.  Experience with CHART. , 1991, International journal of radiation oncology, biology, physics.

[16]  S Majewski,et al.  Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Initial experience with a practical hyperfractionated accelerated radiotherapy regimen. , 1991, International journal of radiation oncology, biology, physics.

[18]  H. Thames,et al.  Clinical evidence for tumor clonogen regeneration: interpretations of the data. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  J F Fowler,et al.  Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  P. Rubin,et al.  interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts new evidence for accelerated proliferation from radiation therapy oncology group protocol 8313 , 1992, Cancer.

[21]  H. Dubben No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  J. Hendry,et al.  The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  D J Brenner,et al.  Dose, volume, and tumor-control predictions in radiotherapy. , 1993, International journal of radiation oncology, biology, physics.